RENB250117C7500
- 0.00
- 0.000.00%
Renovaro Newsroom
Press Release: Renovaro Inc. Appoints Maurice Van Tilburg to Lead GEDi Cube BV
US Stocks Gain, Nasdaq Surges Over 100 Points
Press Release: RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program
Renovaro Regains Compliance With NASDAQ Listing Requirement
Express News | Renovaro Regains Compliance With Nasdaq Listing Requirement
Sector Update: Health Care Stocks Advance in Afternoon Trading
Express News | Renovaro Inc - Renovaro Cube to Deploy Nvidia Superpod With Dgx B200 Systems
Express News | Renovaro Enters Into a Strategic Collaboration With Nebul to Advance a Paradigm Shift for Early Disease Detection
Renovaro | 10-Q: Q1 2025 Earnings Report
Renovaro Biosciences Appoints Simon Tarsh as Interim CFO
Express News | Renovaro Issues Shareholder Letter and Provides Corporate Update
Express News | Renovaro Inc Files for Mixed Shelf Offering of up to $200 Mln- SEC Filing
Renovaro | 10-K/A: Annual report (Amendment)
12 Health Care Stocks Moving In Thursday's Intraday Session
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using Oxford Nanopore Sequencing
Sector Update: Health Care Stocks Rise Late Afternoon
Renovaro Names David Weinstein CEO Amid Restructuring, Board Reshuffle
Renovaro Shares Are Trading Higher. The Company Appointed a New CEO and Board Member.
Renovaro Appoints 4 New Directors -- Maurice Van Tilburg, Douglas Calder, James McNulty, and Mark Collins >RENB
Express News | Renovaro Inc - Realignment to Optimize and Commercialize Renovarocube AI Platform